Papanek Julie Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 1,800 shares at $20.00 ($36K) on 2022-07-05, disclosed to the SEC on 2022-07-12.
Scheduled sale ($36k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 1,000 | $20K | 55.6% |
| 2 | $20.00 | 800 | $16K | 44.4% |
| Total | $20.00 avg | 1,800 | $36K | 100% |
| Filing → |
| DAWN | SELL | 2022-08-08 | $200K | — | Filing → |
| DAWN | SELL | 2022-07-20 | $52K | — | Filing → |
| DAWN | SELL | 2022-07-12 | $25K | — | Filing → |